Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000482552 | SCV000573978 | uncertain significance | not provided | 2017-03-15 | criteria provided, single submitter | clinical testing | The G1711A variant in the RP1L1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The G1711A variant is observed in 53/8626 (0.6%) alleles from individuals of East Asian background in the ExAC dataset (Lek et al., 2016). The G1711A variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. We interpret G1711A as a variant of uncertain significance. |
Fulgent Genetics, |
RCV002496876 | SCV002783691 | uncertain significance | Occult macular dystrophy; Retinitis pigmentosa 88 | 2021-07-02 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003889908 | SCV004705840 | likely benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |